Last reviewed · How we verify

NCT05888545

Clinical Study on a Novel Anti-adhesion Barrier Film

Status unknown NA Last updated 23 February 2024
What this trial tests

NA trial testing anti-adhesion diaphragm in Intrauterine Adhesion in 1,176 participants. Status unknown.

Timeline
1 April 2023
Primary endpoint
1 December 2024
31 December 2024

Quick facts

Lead sponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment1,176
Start date1 April 2023
Primary completion1 December 2024
Estimated completion31 December 2024
Sites8 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Who can join

Adults 18 to 40, female only, with Intrauterine Adhesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical study was to verify the effectiveness and safety of the anti-adhesion diaphragm in preventing intrauterine adhesions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Intrauterine Adhesion

Currently open trials in the same condition.

Other The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05888545.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing